AU2001277032A1 - 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7 ones - Google Patents
2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7 onesInfo
- Publication number
- AU2001277032A1 AU2001277032A1 AU2001277032A AU7703201A AU2001277032A1 AU 2001277032 A1 AU2001277032 A1 AU 2001277032A1 AU 2001277032 A AU2001277032 A AU 2001277032A AU 7703201 A AU7703201 A AU 7703201A AU 2001277032 A1 AU2001277032 A1 AU 2001277032A1
- Authority
- AU
- Australia
- Prior art keywords
- dialkoxyphenyl
- pyrido
- pyrimidin
- pyridyl
- ones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22308300P | 2000-08-04 | 2000-08-04 | |
US60223083 | 2000-08-04 | ||
PCT/US2001/022881 WO2002012238A2 (en) | 2000-08-04 | 2001-07-20 | 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001277032A1 true AU2001277032A1 (en) | 2002-02-18 |
Family
ID=22834955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001277032A Abandoned AU2001277032A1 (en) | 2000-08-04 | 2001-07-20 | 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7 ones |
Country Status (21)
Country | Link |
---|---|
US (1) | US7022711B2 (de) |
EP (1) | EP1307450B1 (de) |
JP (1) | JP2004519422A (de) |
AP (1) | AP1333A (de) |
AR (1) | AR030310A1 (de) |
AT (1) | ATE408613T1 (de) |
AU (1) | AU2001277032A1 (de) |
BR (1) | BR0112857A (de) |
CA (1) | CA2417942C (de) |
DE (1) | DE60135854D1 (de) |
DO (1) | DOP2001000227A (de) |
ES (1) | ES2311532T3 (de) |
GT (1) | GT200100158A (de) |
HN (1) | HN2001000171A (de) |
MX (1) | MXPA02011263A (de) |
PA (1) | PA8524101A1 (de) |
PE (1) | PE20020305A1 (de) |
SV (1) | SV2002000572A (de) |
TN (1) | TNSN01118A1 (de) |
UY (1) | UY26867A1 (de) |
WO (1) | WO2002012238A2 (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03000865A (es) * | 2000-08-04 | 2003-06-18 | Warner Lambert Co | Proceso para preparar 2-(4-piridil) amino-6-dialquiloxifenil-pirido (2,3-d)pirimidin-7-onas. |
JP2004505974A (ja) * | 2000-08-04 | 2004-02-26 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 2−(4−ピリジル)アミノ−6−ジアルキルオキシフェニルピリド〔2,3−d〕ピリミジン−7−オン類の製造方法 |
NZ534069A (en) | 2002-01-22 | 2007-03-30 | Warner Lambert Co | 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones to be used to treat neurodegenerative disorders, viruses and cancer |
PA8577501A1 (es) * | 2002-07-25 | 2004-02-07 | Warner Lambert Co | Inhibidores de quinasas |
AU2003258542A1 (en) * | 2002-07-29 | 2004-02-23 | Axxima Pharmaceuticals Ag | Method for isolating atp binding proteins by means of immobolized protein inhibitors |
CN100420687C (zh) * | 2002-12-20 | 2008-09-24 | 霍夫曼-拉罗奇有限公司 | 作为选择性kdr和fgfr抑制剂的吡啶并[2,3-d]嘧啶衍生物 |
US7098332B2 (en) * | 2002-12-20 | 2006-08-29 | Hoffmann-La Roche Inc. | 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones |
US7687625B2 (en) | 2003-03-25 | 2010-03-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
CN1867560A (zh) | 2003-08-13 | 2006-11-22 | 武田药品工株式会社 | 4-嘧啶酮衍生物及其作为肽基肽酶抑制剂的用途 |
JP2007505121A (ja) | 2003-09-08 | 2007-03-08 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
AU2004289304A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Pyridine compounds |
ATE481134T1 (de) * | 2004-01-21 | 2010-10-15 | Univ Emory | Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
CN102079743B (zh) | 2004-03-15 | 2020-08-25 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
JP2008501714A (ja) | 2004-06-04 | 2008-01-24 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼインヒビター |
FR2873118B1 (fr) | 2004-07-15 | 2007-11-23 | Sanofi Synthelabo | Derives de pyrido-pyrimidine, leur application en therapeutique |
WO2006019965A2 (en) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
WO2006038112A1 (en) * | 2004-10-01 | 2006-04-13 | Warner-Lambert Company Llc | Use of kinase inhibitors to promote neochondrogenesis |
WO2006068978A2 (en) | 2004-12-21 | 2006-06-29 | Takeda Pharmaceutial Company Limited | Dipeptidyl peptidase inhibitors |
FR2887882B1 (fr) | 2005-07-01 | 2007-09-07 | Sanofi Aventis Sa | Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique |
DK1942898T4 (da) | 2005-09-14 | 2014-06-02 | Takeda Pharmaceutical | Dipeptidylpeptidase-inhibitorer til behandling af diabetes |
KR101368988B1 (ko) | 2005-09-16 | 2014-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 디펩티딜 펩티다제 억제제 |
FR2896246B1 (fr) | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
AU2007296556B2 (en) * | 2006-09-13 | 2013-09-19 | Takeda Pharmaceutical Company Limited | Use of 2-6- (3-Amino-piperidin-1-yl) -3-methyl-2, 4-dioxo-3, 4-dihydro-2H-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile |
JP2010509265A (ja) * | 2006-11-09 | 2010-03-25 | エフ.ホフマン−ラ ロシュ アーゲー | キナーゼ阻害剤としての置換6−フェニル−ピリド[2,3−d]ピリミジン−7−オン誘導体及びそれの使用方法 |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
JP5442449B2 (ja) | 2006-12-22 | 2014-03-12 | アステックス、セラピューティックス、リミテッド | 新規化合物 |
US8131527B1 (en) | 2006-12-22 | 2012-03-06 | Astex Therapeutics Ltd. | FGFR pharmacophore compounds |
AR064491A1 (es) | 2006-12-22 | 2009-04-08 | Astex Therapeutics Ltd | Derivados de imidazo[1, 2-a]pirimidina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por las quinasas fgfr. |
FR2910813B1 (fr) | 2006-12-28 | 2009-02-06 | Sanofi Aventis Sa | Nouvelle utilisation therapeutique pour le traitement des leucemies |
WO2008104473A2 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Pyrazolopyriidine derivatives and their use as kinase inhibitors |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
EP2400985A2 (de) | 2009-02-25 | 2012-01-04 | OSI Pharmaceuticals, LLC | Kombination eines anti-igf-1r-antikörpers oder eines igf-bindungsproteins und eines kleinmoleküligen igf-1r-kinase-inhibitors |
US8642834B2 (en) | 2009-02-27 | 2014-02-04 | OSI Pharmaceuticals, LLC | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
US8465912B2 (en) | 2009-02-27 | 2013-06-18 | OSI Pharmaceuticals, LLC | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
WO2010099138A2 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
CN101671336B (zh) | 2009-09-23 | 2013-11-13 | 辽宁利锋科技开发有限公司 | 芳杂环并嘧啶衍生物和类似物及其制备方法和用途 |
EP2589592B1 (de) | 2010-06-30 | 2018-08-22 | FUJIFILM Corporation | Neue nikotinamid-derivate oder salze davon |
EP2702173A1 (de) | 2011-04-25 | 2014-03-05 | OSI Pharmaceuticals, LLC | Verwendung von emt-gensignaturen bei der entdeckung von krebswirkstoffen, -diagnostika und -behandlungen |
WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
SG11201500125QA (en) | 2012-07-11 | 2015-02-27 | Blueprint Medicines Corp | Inhibitors of the fibroblast growth factor receptor |
AU2014228746B2 (en) | 2013-03-15 | 2018-08-30 | Celgene Car Llc | Heteroaryl compounds and uses thereof |
TWI647220B (zh) | 2013-03-15 | 2019-01-11 | 美商西建卡爾有限責任公司 | 雜芳基化合物及其用途 |
CA2907243C (en) | 2013-03-15 | 2021-12-28 | Celgene Avilomics Research, Inc. | Substituted dihydropyrimidopyrimidinone compounds and pharmaceutical compositions thereof use fgfr4 inhibitor |
WO2015061572A1 (en) | 2013-10-25 | 2015-04-30 | Blueprint Medicines Corporation | Inhibitors of the fibroblast growth factor receptor |
US9695165B2 (en) | 2014-01-15 | 2017-07-04 | Blueprint Medicines Corporation | Inhibitors of the fibroblast growth factor receptor |
CN105294682B (zh) | 2014-07-26 | 2017-07-07 | 广东东阳光药业有限公司 | Cdk类小分子抑制剂的化合物及其用途 |
US10449195B2 (en) | 2016-03-29 | 2019-10-22 | Shenzhen Pharmacin Co., Ltd. | Pharmaceutical formulation of palbociclib and a preparation method thereof |
NZ749275A (en) | 2016-07-01 | 2023-06-30 | G1 Therapeutics Inc | Synthesis of n-(heteroaryl)-pyrrolo[2,3-d]pyrimidin-2-amines |
EP3587419A4 (de) * | 2017-02-27 | 2020-08-05 | Betta Pharmaceuticals Co., Ltd. | Fgfr-inhibitor und anwendung davon |
SG11202101807SA (en) | 2018-08-24 | 2021-03-30 | G1 Therapeutics Inc | Improved synthesis of 1,4-diazaspiro[5.5]undecan-3-one |
EP3792261A4 (de) * | 2018-09-14 | 2021-05-05 | Abbisko Therapeutics Co., Ltd. | Fgfr4-inhibitor, herstellungsverfahren dafür und anwendung davon |
WO2020140055A1 (en) * | 2018-12-28 | 2020-07-02 | Spv Therapeutics Inc. | Cyclin-dependent kinase inhibitors |
CN114306245A (zh) | 2020-09-29 | 2022-04-12 | 深圳市药欣生物科技有限公司 | 无定形固体分散体的药物组合物及其制备方法 |
EP4274546A1 (de) * | 2021-01-06 | 2023-11-15 | The Penn State Research Foundation | Verfahren und materialien zur behandlung von haarausfall |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620981A (en) * | 1995-05-03 | 1997-04-15 | Warner-Lambert Company | Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
US5945422A (en) * | 1997-02-05 | 1999-08-31 | Warner-Lambert Company | N-oxides of amino containing pyrido 2,3-D! pyrimidines |
MXPA03000865A (es) * | 2000-08-04 | 2003-06-18 | Warner Lambert Co | Proceso para preparar 2-(4-piridil) amino-6-dialquiloxifenil-pirido (2,3-d)pirimidin-7-onas. |
JP2004505974A (ja) * | 2000-08-04 | 2004-02-26 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 2−(4−ピリジル)アミノ−6−ジアルキルオキシフェニルピリド〔2,3−d〕ピリミジン−7−オン類の製造方法 |
-
2001
- 2001-07-20 WO PCT/US2001/022881 patent/WO2002012238A2/en active Application Filing
- 2001-07-20 MX MXPA02011263A patent/MXPA02011263A/es active IP Right Grant
- 2001-07-20 CA CA2417942A patent/CA2417942C/en not_active Expired - Fee Related
- 2001-07-20 US US10/343,847 patent/US7022711B2/en not_active Expired - Fee Related
- 2001-07-20 AU AU2001277032A patent/AU2001277032A1/en not_active Abandoned
- 2001-07-20 DE DE60135854T patent/DE60135854D1/de not_active Expired - Lifetime
- 2001-07-20 BR BR0112857-4A patent/BR0112857A/pt not_active IP Right Cessation
- 2001-07-20 JP JP2002518213A patent/JP2004519422A/ja active Pending
- 2001-07-20 ES ES01954811T patent/ES2311532T3/es not_active Expired - Lifetime
- 2001-07-20 AP APAP/P/2001/002230A patent/AP1333A/en active
- 2001-07-20 AT AT01954811T patent/ATE408613T1/de not_active IP Right Cessation
- 2001-07-20 EP EP01954811A patent/EP1307450B1/de not_active Expired - Lifetime
- 2001-07-27 SV SV2001000572A patent/SV2002000572A/es not_active Application Discontinuation
- 2001-08-01 TN TNTNSN01118A patent/TNSN01118A1/en unknown
- 2001-08-03 GT GT200100158A patent/GT200100158A/es unknown
- 2001-08-03 HN HN2001000171A patent/HN2001000171A/es unknown
- 2001-08-03 PA PA20018524101A patent/PA8524101A1/es unknown
- 2001-08-03 AR ARP010103716A patent/AR030310A1/es not_active Application Discontinuation
- 2001-08-03 UY UY26867A patent/UY26867A1/es not_active Application Discontinuation
- 2001-08-03 PE PE2001000776A patent/PE20020305A1/es not_active Application Discontinuation
- 2001-08-03 DO DO2001000227A patent/DOP2001000227A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ATE408613T1 (de) | 2008-10-15 |
TNSN01118A1 (en) | 2005-11-10 |
UY26867A1 (es) | 2001-10-25 |
US7022711B2 (en) | 2006-04-04 |
MXPA02011263A (es) | 2003-03-10 |
BR0112857A (pt) | 2005-02-09 |
US20030220345A1 (en) | 2003-11-27 |
PA8524101A1 (es) | 2002-10-24 |
EP1307450A2 (de) | 2003-05-07 |
AR030310A1 (es) | 2003-08-20 |
CA2417942A1 (en) | 2002-02-14 |
DOP2001000227A (es) | 2002-12-15 |
GT200100158A (es) | 2002-07-18 |
WO2002012238A3 (en) | 2002-05-10 |
AP2001002230A0 (en) | 2001-09-30 |
JP2004519422A (ja) | 2004-07-02 |
HN2001000171A (es) | 2001-09-21 |
WO2002012238A2 (en) | 2002-02-14 |
PE20020305A1 (es) | 2002-05-09 |
ES2311532T3 (es) | 2009-02-16 |
EP1307450B1 (de) | 2008-09-17 |
DE60135854D1 (de) | 2008-10-30 |
CA2417942C (en) | 2010-06-29 |
SV2002000572A (es) | 2002-07-18 |
AP1333A (en) | 2004-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001277032A1 (en) | 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7 ones | |
HUS1700019I1 (hu) | 2-(Piridin-2-il-amino)-pirido[2,3-d]pirimidin-7-onok | |
EP1416935B8 (de) | 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidin derivate | |
HK1062300A1 (en) | 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d)pyrimidine derivatives | |
AU2002220692A1 (en) | Novel pyridine-substituted pyrazolopyridine derivatives | |
AUPR154400A0 (en) | Robot machine | |
AU756649C (en) | Compact case forming machine | |
AU2002337359A1 (en) | An autonomous machine | |
AU2001230026A1 (en) | 2,4-diaminothiazole derivatives | |
AU2001262271A1 (en) | Substituted iminoazines used as herbicides | |
PT1210349E (pt) | Pirazolo-¬4,3-d|-pirimidinas | |
AU2002233101A1 (en) | Coffee machine | |
PL358551A1 (en) | 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines | |
AU6594401A (en) | 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines | |
AU2001275188A1 (en) | Communicating objects between users | |
AU2002218400A1 (en) | 3-substituted 2,7-naphthyridin-1-yl derivatives | |
AU2001278908A1 (en) | Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido(2,3-d)pyrimidin 7-ones | |
AU2001298008A1 (en) | Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido (2,3-d)pyrimidin-7-ones | |
AU2001233026A1 (en) | Phosphodiesterases | |
AU8578501A (en) | 2-aminoalkyl-thieno(2,3-d)pyrimidines | |
AU2001285785A1 (en) | 2-aminoalkyl-thieno[2,3-d]pyrimidines | |
AU5822601A (en) | Headstock | |
AU6390001A (en) | 6,10-dimethyl-5,9-undecadien-2-ol | |
AU2002223710A1 (en) | Pressure-fluid-driven machine | |
AU2001234795A1 (en) | Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one |